Merck Invests €300 million in new Bioprocessing Center in South Korea
Merck invests over €300 million in a new Bioprocessing Production Center in South Korea to support biologics development, create jobs, and expand its presence in the Asia-Pacific region.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
